Indero is proud to announce the successful completion of an internally funded study that introduces a novel approach to evaluating topical new chemical entities (NCE) in early-phase clinical research.
To continue reading click here
Indero announces breakthrough method for early-phase evaluation of topical drugs using quantitative gene expression
